Drugs / Bifilact®
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT01839721 Comparator | Dec 2006 → Nov 2010 | cancer, diarrheal disease | CHU de Quebec-Universite Laval | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bifilact | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01839721 ↗ |
| Modality | Other / unclassified | “the probiotic Bifilact(®)” PMID 24200199 ↗ Oct 2013 |